WallStreetZenWallStreetZen

NASDAQ: VYNE
Vyne Therapeutics Inc Stock Ownership - Who owns Vyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tyler ZerondaCHIEF FINANCIAL OFFICER2025-09-303,420$0.34
$1.15kSell
David DomzalskiPRESIDENT AND CEO2025-09-3012,676$0.34
$4.25kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-09-303,581$0.34
$1.20kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2025-09-302,453$0.34
$821.76Sell
Iain StuartCHIEF SCIENTIFIC OFFICER2025-06-302,453$1.65
$4.05kSell
David DomzalskiPRESIDENT AND CEO2025-06-3012,676$1.65
$20.92kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-06-303,581$1.65
$5.91kSell
Tyler ZerondaCHIEF FINANCIAL OFFICER2025-06-303,420$1.65
$5.64kSell
David DomzalskiPRESIDENT AND CEO2025-06-028,681$0.81
$7.03kBuy
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-06-021,145$0.81
$927.45Buy

1 of 2

VYNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYNE insiders and whales buy or sell their stock.

VYNE Shareholders

What type of owners hold Vyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC14.93%4,935,057$1.86MInsider
Vivo Capital VIII LLC12.14%4,011,236$1.51MInsider
Albert Cha12.14%4,011,236$1.51MInsider
Remeditex Ventures LLC8.36%2,761,663$1.04MInsider
Presidio Partners 2007 GP LP7.89%2,608,540$980.81kInsider
Venbio Global Strategic Fund II LP4.42%1,461,552$549.54kInsider
Merck Co Inc3.76%1,243,168$467.43kInsider
Fmr LLC3.38%1,118,054$420.39kInsider
Ai Biotechnology LLC3.38%1,116,585$419.84kInsider
Steven L. Basta2.58%853,942$321.08kInsider

1 of 3

VYNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYNE12.04%78.86%Net SellingNet Selling
PLRZ1.26%0.00%
IMNN1.72%98.28%Net Buying
PHIO0.18%99.82%Net BuyingNet Buying
CURX1.01%8.69%
View Top Biotech Stocks

Vyne Therapeutics Stock Ownership FAQ

Who owns Vyne Therapeutics?

Vyne Therapeutics (NASDAQ: VYNE) is owned by 12.04% institutional shareholders, 78.86% Vyne Therapeutics insiders, and 9.10% retail investors. Perceptive Advisors LLC is the largest individual Vyne Therapeutics shareholder, owning 4.94M shares representing 14.93% of the company. Perceptive Advisors LLC's Vyne Therapeutics shares are currently valued at $1.86M.

If you're new to stock investing, here's how to buy Vyne Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.